NIH-funded research R21 grant

Investigating a new therapy for age-related hearing loss

Official title: Sex Effects for Hearing Loss Drug Therapies

Funded at University of South Florida · NIH-10791076 · Data updated 2026-11-12

This study is looking at how a natural supplement called L-ergothioneine might help improve hearing for older adults dealing with age-related hearing loss, since there aren't any approved treatments for this condition yet.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of South Florida
NIH-funded
Lab location1 site (Tampa, United States)
Project startSeptember 25, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$412,500
NIH project number1R21DC021546-01
Project IDNIH-10791076 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing age-related hearing loss.

Less likely to help

Patients with hearing loss due to non-age-related factors may not benefit from this research.

What this research studies

This research focuses on age-related hearing loss (ARHL), a common condition affecting older adults, which leads to gradual deterioration in hearing abilities. The study aims to explore the therapeutic potential of L-ergothioneine, a natural antioxidant and anti-inflammatory agent, to target multiple pathways involved in hearing loss. By investigating this therapy, the research seeks to provide a new approach to managing ARHL, which currently has no FDA-approved treatments. Patients may be involved in trials to assess the effectiveness of this therapy in improving their hearing and overall quality of life.

Why it matters

Potential benefit: If successful, this research could lead to a new treatment option for age-related hearing loss, improving communication and quality of life for older adults.

How similar studies have gone: While there have been studies on antioxidants for hearing loss, this specific approach targeting multiple pathways with L-ergothioneine is novel and has not been extensively tested.

Where this research is happening

  • University of South Florida
    Tampa, United States
    Active

Researchers

  • Principal investigator: Frisina, Robert D — University of South Florida
  • Study coordinator: Frisina, Robert D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.